0000950123-11-048901.txt : 20110511 0000950123-11-048901.hdr.sgml : 20110511 20110511162631 ACCESSION NUMBER: 0000950123-11-048901 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20110511 DATE AS OF CHANGE: 20110511 GROUP MEMBERS: RICHARD E. AZAR* GROUP MEMBERS: VALUE ASSETS INTERNATIONAL S.A. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CHINA-BIOTICS, INC CENTRAL INDEX KEY: 0001271057 STANDARD INDUSTRIAL CLASSIFICATION: MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400] IRS NUMBER: 980393071 STATE OF INCORPORATION: DE FISCAL YEAR END: 0305 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-82509 FILM NUMBER: 11832242 BUSINESS ADDRESS: STREET 1: NO 999 NINGQIAO ROAD, JINQIAO EXPORT PRO STREET 2: PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201206 BUSINESS PHONE: 86 21 5834 9748 MAIL ADDRESS: STREET 1: NO 999 NINGQIAO ROAD, JINQIAO EXPORT PRO STREET 2: PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201206 FORMER COMPANY: FORMER CONFORMED NAME: OTISH RESOURCES INC DATE OF NAME CHANGE: 20031121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Value Holdings Capital S.A. CENTRAL INDEX KEY: 0001520053 IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 7-9 ST. CLAIR PLACE, 2ND FLOOR STREET 2: ST. CLAIR AVENUE CITY: PORT OF SPAIN STATE: W5 ZIP: 0 BUSINESS PHONE: 868 680 9999 MAIL ADDRESS: STREET 1: 7-9 ST. CLAIR PLACE, 2ND FLOOR STREET 2: ST. CLAIR AVENUE CITY: PORT OF SPAIN STATE: W5 ZIP: 0 SC 13G 1 g27213sc13g.htm SC 13G sc13g

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )*

China-Biotics, Inc.
(Name of Issuer)
Common Stock, par value $0.0001
(Title of Class of Securities)
16937B109
(CUSIP Number)
May 2, 2011
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     þ Rule 13d-1(c)

     o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 


 

                     
CUSIP No.
 
16937B109 
 

 

           
1   NAMES OF REPORTING PERSONS
VALUE HOLDINGS CAPITAL, S.A.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  BRITISH VIRGIN ISLANDS
       
  5   SOLE VOTING POWER
     
NUMBER OF   -0-
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,536,336
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   -0-
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,536,336
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,536,336
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  7%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  FI

2


 

                     
CUSIP No.
 
16937B109 
 

 

           
1   NAMES OF REPORTING PERSONS
VALUE ASSETS INTERNATIONAL S.A.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  BRITISH VIRGIN ISLANDS
       
  5   SOLE VOTING POWER
     
NUMBER OF   -0-
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   264,224
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   -0-
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    264,224
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  264,224
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  1.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  FI

3


 

                     
CUSIP No.
 
16937B109 
 

 

           
1   NAMES OF REPORTING PERSONS
RICHARD E. AZAR*
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  TRINIDAD TOBAGO
       
  5   SOLE VOTING POWER
     
NUMBER OF   -0-
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,800,560
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   -0-
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,800,560
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,800,560
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  8.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* RICHARD E. AZAR IS THE SOLE DIRECTOR AND OWNER OF VALUE HOLDINGS CAPITAL, S.A. AND VALUE ASSETS INTERNATIONAL, S. A. WHICH OWN 1,536,336 AND 264,224 CHINA-BIOTICS, INC. COMMON SHARES, RESPECTIVELY. THEREFORE, MR. AZAR COULD BE DEEMED TO BE BENEFICIAL OWNER OF THE 1,800,560 SHARES OF CHINA-BIOTICS, INC.

4


 

 
Item 1.
Item 1(a) Name of issuer: CHINA-BIOTICS, INC.
Item 1(b) Address of issuer’s principal executive offices: NO. 999 NINGQIAO ROAD, JINQIAO EXPORT PROCESSING ZONE, PUDONG, SHANGHAI 201206, PEOPLE’S REPUBLIC OF CHINA
Item 2.
2(a) Name of person filing: THIS STATEMENT IF FILED ON BEHALF OF VALUE HOLDINGS CAPITAL, S.A. (“VALUE HOLDINGS”), VALUE ASSETS INTERNATIONAL, S.A. (“VALUE ASSETS”), AND RICHARD E. AZAR (“AZAR”). VALUE HOLDINGS BENEFICIALLY OWNS 1, 536,336 SHARES OF THE ISSUER’S COMMON STOCK; VALUE ASSETS BENEFICIALLY OWNS 264,224 SHARES OF THE ISSUER’S COMMON STOCK. VALUE ASSETS AND VALUE HOLDING DECLARE THAT NEITHER THE FILING OF THIS STATEMENT NOR ANYTHING HEREIN SHALL BE CONSTRUED AS AN ADMISSION THAT SUCH REPORTING PERSON IS, FOR THE PURPOSE OF SECTION 13(d) or 13(g) OF THE ACT OR ANY OTHER PURPOSE, THE BENEFICIAL OWNER OF ANY SECURITIES HELD BY OR FOR THE OTHER. EACH OF VALUE ASSETS AND VALUE HOLDINGS MAY BE DEEMED TO BE A MEMBER OF A GROUP WITH RESPECT TO THE SECURITIES OF THE ISSUER FOR THE PURPOSE OF SECTION 13(d) or 13(g) OF THE ACT. VALUE ASSETS AND VALUE HOLDING DECLARE THAT THAT NEITHER THE FILING OF THIS STATEMENT NOR ANYTHING HEREIN SHALL BE CONSTRUED AS AN ADMISSION THAT SUCH REPORTING PERSON IS, FOR THE PURPOSE OF SECTION 13(d) or 13(g) OF THE ACT OR ANY OTHER PURPOSE, (I) ACTING (OR HAS AGREED OR IS AGREEING TO ACT TOGETHER WITH ANY OTHER PERSON) AS A PARTNERSHIP, LIMITED PARTNERSHIP,SYNDICATE, OR OTHER GROUP FOR THE PURPOSE OF ACQUIRING,HOLDING, OR DISPOSING OF SECURITIES OF THE ISSUER OR OTHERWISE WITH RESPECT TO THE ISSUER OR ANY SECURITIES OF THE ISSUER, OR (II) A MEMBER OF ANY GROUP WITH RESPECT TO THE ISSUER OR ANY SECURITIES OF THE ISSUER.
RICHARD E. AZAR IS THE SOLE DIRECTOR AND OWNER OF VALUE HOLDINGS CAPITAL S.A. AND VALUE ASSETS INTERNATIONAL, S. A. WHICH OWN 1,536,336 AND 264,224 CHINA-BIOTICS, INC. COMMON SHARES, RESPECTIVELY. THEREFORE, MR. AZAR COULD BE DEEMED TO BE BENEFICIAL OWNER OF THE 1,800,560 SHARES OF CHINA-BIOTICS, INC.
THE REPORTING PERSONS HAVE ENTERED INTO A JOINT FILING AGREEMENT, A COPY OF WHICH IS FILED WITH THIS STATEMENT AS EXHIBIT 99.1, PURSUANT TO WHICH THEY HAVE AGREED TO FILE THIS SCHEDULE13G JOINTLY IN ACCORDANCE WITH THE PROVISIONS OF RULE 13D-1(K) OF THE ACT.
2(b) Address or principal business office or, if none, residence: VALUE ASSETS, VALUE HOLDINGS AND AZAR: 7-9 ST. CLAIR PLACE, 2ND FL., ST. CLAIR AVE., PORT OF SPAIN, TRINIDAD AND TOBAGO
2(c) Citizenship: (i) VALUE ASSETS, VALUE HOLDINGS: BRITISH VIRGIN ISLANDS; (ii) AZAR: TRINIDAD TOBAGO
2(d) Title of class of securities: COMMON STOCK, PAR VALUE $0.0001
2(e) CUSIP No.: 16937B109
 

5


 

Item 3. NOT APPLICABLE
If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
  a.o   Broker or dealer registered under Section 15 of the Act;
 
  b.o   Bank as defined in Section 3(a)(6) of the Act;
 
  c.o   Insurance company as defined in Section 3(a)(19) of the Act;
 
  d.o   Investment company registered under Section 8 of the Investment Company Act of 1940;
 
  e.o   An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
 
  f.o   An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
 
  g.o   A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
 
  h.o   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
  i.o   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
 
  j.o   A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
 
  k.o   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:                          
 
     
 

6


 

Item 4. Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. FOR PURPOSES OF DETERMINING THE PERCENTAGE OF OUTSTANDING SHARES WITH RESPECT TO THIS STATEMENT THE REPORTING PERSONS HAVE RELIED UPON INFORMATION OBTAINED FROM THE ISSUER THAT THE AGGREGATE NUMBER OF OUTSTANDING SHARES OF COMMON STOCK OF THE ISSUER AS REFLECTED ON THE 12.31.10 FORM 10Q WAS 22,150,200 (As OF FEBRUARY 10, 2011).
VALUE HOLDINGS
  a.   Amount beneficially owned: 1,536,336
 
  b.   Percent of class 7%
 
  c.   Number of shares as to which such person has:
  i.   Sole power to vote or to direct the vote -0-
 
  ii.   Shared power to vote or to direct the vote 1,536,336
 
  iii.   Sole power to dispose or to direct the disposition of -0-
 
  iv.   Shared power to dispose or to direct the disposition of 1,536,336
VALUE ASSETS
  a.   Amount beneficially owned: 264,224
 
  b.   Percent of class 1.1%
 
  c.   Number of shares as to which such person has:
  i.   Sole power to vote or to direct the vote -0-
 
  ii.   Shared power to vote or to direct the vote 264,224
 
  iii.   Sole power to dispose or to direct the disposition of -0-
 
  iv.   Shared power to dispose or to direct the disposition of 264,224
AZAR
  a.   Amount beneficially owned: 1,800,560*
 
  b.   Percent of class 8.1%
 
  c.   Number of shares as to which such person has:
  i.   Sole power to vote or to direct the vote -0-
 
  ii.   Shared power to vote or to direct the vote 1,800,560
 
  iii.   Sole power to dispose or to direct the disposition of -0-
 
  iv.   Shared power to dispose or to direct the disposition of 1,800,560
 
*   RICHARD E. AZAR IS THE SOLE DIRECTOR AND OWNER OF VALUE HOLDINGS CAPITAL S.A. AND VALUE ASSETS INTERNATIONAL, S. A. WHICH OWN 1,536,336 AND 264,224 CHINA-BIOTIC, INC. COMMON SHARES, RESPECTIVELY. THEREFORE, MR. AZAR COULD BE DEEMED TO BE BENEFICIAL OWNER OF THE 1,800,560 SHARES OF CHINA-BIOTICS, INC.

7


 

 
Instruction. For computations regarding securities which represent a right to acquire an underlying security see Rule 13d-3(d)(1).
 
Item 5. NOT APPLICABLE
Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ].
Instruction. Dissolution of a group requires a response to this item.
 
Item 6. Ownership of More than 5 Percent on Behalf of Another Person
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. * RICHARD E. AZAR IS THE SOLE DIRECTOR AND OWNER OF VALUE HOLDINGS AND VALUE ASSETS WHICH OWN 1,536,336 AND 264,224 CHINA-BIOTIC, INC. COMMON SHARES, RESPECTIVELY. THEREFORE, MR. AZAR COULD BE DEEMED TO BE BENEFICIAL OWNER OF THE 1,800,560 SHARES OF CHINA-BIOTICS, INC. OWNED BY VALUE HOLDINGS AND VALUE ASSETS.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. NOT APPLICABLE
If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
 

8


 

 
Item 8. Identification and Classification of Members of the Group NOT APPLICABLE
If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group.
 
Item 9. Notice of Dissolution of Group NOT APPLICABLE
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
 
Item 10. Certifications
  a.   The following certification shall be included if the statement is filed pursuant to Rule 13d-1(b):
 
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
  b.   The following certification shall be included if the statement is filed pursuant to Rule 240.13d-1(b)(1)(ii)(J), or if the statement is filed pursuant to Rule 240.13d-1(b)(1)(ii)(K) and a member of the group is a non-U.S. institution eligible to file pursuant to Rule 240.13d-1(b)(1)(ii)(J):
 
      By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to [insert particular category of institutional investor] is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.
 
  c.   The following certification shall be included if the statement is filed pursuant to Rule 13d-1(c):
 
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
Signature.
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

9


 

VALUE HOLDINGS CAPITAL, S.A.
signature
BY: RICHARD E. AZAR, Name/Title
DIRECTOR
Dated: May 11, 2011
VALUE ASSETS INTERNATIONAL, S.A.
signature
BY: RICHARD E. AZAR, Name/Title
DIRECTOR
Dated: May 11, 2011
RICHARD E. AZAR
By: RICHARD E. AZAR

Signature
RICHARD E. AZAR, DIRECTOR
Name/Title
Dated: May 11, 2011

10 EX-99.1 2 g27213exv99w1.htm EX-99.1 exv99w1

Exhibit 99.1
JOINT FILING AGREEMENT
This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, $.0001 par value, of China-Biotics, Inc., a Delaware corporation, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in a accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
Dated: May 11, 2011.
VALUE HOLDINGS CAPITAL, S.A.
signature
BY: RICHARD E. AZAR, Name/Title
DIRECTOR
Dated: May 11, 2011
VALUE ASSETS INTERNATIONAL, S.A.
signature
BY: RICHARD E. AZAR, Name/Title
DIRECTOR
Dated: May 11, 2011
RICHARD E. AZAR
By: RICHARD E. AZAR

Signature
RICHARD E. AZAR, DIRECTOR
Name/Title
Dated: May 11, 2011
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties for whom copies are to be sent.
 
Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).